Hussain M N, Culbreth W, Dalrymple R, Fung C, Ricks C
Proc Soc Exp Biol Med. 1987 May;185(1):89-92. doi: 10.3181/00379727-185-42522.
A rapid and sensitive competitive receptor binding assay for beta-1 and beta-2 adrenergic binding for adrenergic agents has been developed. The steps that are critical for the success of the assay are given in detail so that the assay can be set up in any routine laboratory with relative ease. The rationale behind the use of specific reagents is discussed. The assay requires microgram quantities of test compound, a radiolabeled specific beta adrenergic antagonist [3H]dihydroalprenolol (DHA), and turkey erythrocyte beta-1 and rat erythrocyte beta-2 receptor membranes. Serial dilutions of sample are incubated with appropriate receptor membranes and DHA for 1 hr at room temperature. After equilibrium is attained, the bound radioligand is separated by rapid filtration under vacuum through Whatman GF/B filters. The amount of bound DHA trapped on the filter is inversely proportional to the degree of beta-1 or beta-2 adrenergic binding of the sample. Separation of bound from free radioligand by filtration permits rapid determination of a large number of samples. This assay quantitates and differentiates beta-1 and beta-2 adrenergic binding of synthetic adrenergic agents.
已开发出一种用于肾上腺素能药物的β-1和β-2肾上腺素能结合的快速灵敏竞争受体结合测定法。详细给出了对于该测定成功至关重要的步骤,以便能在任何常规实验室相对轻松地建立该测定法。讨论了使用特定试剂背后的基本原理。该测定法需要微克量的测试化合物、一种放射性标记的特异性β肾上腺素能拮抗剂[3H]二氢阿普洛尔(DHA)以及火鸡红细胞β-1和大鼠红细胞β-2受体膜。将样品的系列稀释液与适当的受体膜和DHA在室温下孵育1小时。达到平衡后,通过在真空下快速过滤通过Whatman GF/B滤器分离结合的放射性配体。捕获在滤器上的结合DHA的量与样品的β-1或β-2肾上腺素能结合程度成反比。通过过滤从游离放射性配体中分离结合物可快速测定大量样品。该测定法定量并区分合成肾上腺素能药物的β-1和β-2肾上腺素能结合。